Content January2010 Purpose Definitions Scope Openness Properconduct Independence Legislation 3 4 7 9 12 13 14 15 21 Requiremen
Purpose Art.1 Pharmaceuticalcompaniesareinon-going dialogueandnegotiationswithpoliticiansand theregulatoryauthoritiesinordertoo
Definitions Art.2 Thefollowingshallapplyintheseethicalrules A)“Politicians”shallbetakentomeanpersons whoaremembersof(orarecandi
• Regionalandmunicipalauthorities • Miscellaneousprivateassociations andcompanies,etc.,wheremembers orownersarepartofthepublics
negotiatingwithdecision-makers.Thismayfor examplebeaPRorcommunicationagency, legalcounsel,etc. F)”Companyrepresentative”shallbe
indialoguewithadecision-makertoreach agreementonortogainsupportforoneofthe company’swishesorproposals. Scope Art.3 Theethicalru
Art.4 Theethicalrulesshallapplyforcompanyrepresentatives’dialogueandnegotiationswith decision-makers(politiciansandofficials)at
Openness Art.6 Thereshallbefullopennessaboutwhoand whatinterestsarerepresentedbythecompany representative.Companyrepresentative
whereinthecompanyremuneratesa decision-maker,cf.theexemptionprovisions inArt.14A,BandC. Art.8 Allpharmaceuticalcompaniesshallbe
theexternalconsultantandthisshallbeplaced inthepublicdomainwhiletheprojectisin progressandatleastforthreemonths. Thepharmaceuti
Requirementforinformation Art.9 Informationpassedtodecision-makersshall bekeptup-to-dateandcompleteandshallnot containincorrect
Properconduct Art.10 Indialogueandnegotiationswithdecisionmakers,properconductshallbeobserved, whichshallincludethat: A)Adecisi
Confidentialinformation Art.11 Thecompanyrepresentativeshallalwaysact withdiscretionandshallfullyrespectinformationobtainedinco
Independence Art.12 Thereshallneverbeanykindoffinancialdependencybetweenpharmaceuticalcompanies ortheirrepresentativeontheoneha
A)Pharmaceuticalcompaniesmayhowever sponsorspecificprofessionalactivities,campaignsandsimilareventsarrangedandheld byanofficial
areaofresponsibilitytoconductdialogueand negotiationswithdecision-makersonbehalfof thepharmaceuticalcompany(e.g.employees respo
thepharmaceuticalcompany,cf.s.23AdvertisingOrder.Remunerationshallonlybeprovided withrespecttosuchprofessionalservicesand shall
noprofessionalpurpose;forexampleprivate gifts,ticketstosporting,culturalorentertainmentevents,travel,holidays,extravagantvisits
company.Aspartoftheabovemeetings,the companyrepresentativemaycoverdecisionmakers’travelexpensesandovernightaccommodation. A)The
Legislation Art.17 Allactivitiesrelatingtodialogueand negotiationswithdecision-makersshallcomply withcurrentlegislation.Ifacoun
Page 1:
Lif’s ethical rules for dialogue and negotiations with decision
Page 2:
Content January2010 Purpose Definitions Scope Openness Properco
Page 3:
Purpose Art.1 Pharmaceuticalcompaniesareinon-going dialogueandn
Page 4:
Definitions Art.2 Thefollowingshallapplyintheseethicalrules A)“
Page 5:
• Regionalandmunicipalauthorities • Miscellaneousprivateassocia
Page 6:
negotiatingwithdecision-makers.Thismayfor examplebeaPRorcommuni
Page 7:
indialoguewithadecision-makertoreach agreementonortogainsupport
Page 8:
Art.4 Theethicalrulesshallapplyforcompanyrepresentatives’dialog
Page 9:
Openness Art.6 Thereshallbefullopennessaboutwhoand whatinterest
Page 10:
whereinthecompanyremuneratesa decision-maker,cf.theexemptionpro
Page 11:
theexternalconsultantandthisshallbeplaced inthepublicdomainwhil
Page 12:
Requirementforinformation Art.9 Informationpassedtodecision-mak
Page 13:
Properconduct Art.10 Indialogueandnegotiationswithdecisionmaker
Page 14:
Confidentialinformation Art.11 Thecompanyrepresentativeshallalw
Page 15:
Independence Art.12 Thereshallneverbeanykindoffinancialdependen
Page 16:
A)Pharmaceuticalcompaniesmayhowever sponsorspecificprofessional
Page 17:
areaofresponsibilitytoconductdialogueand negotiationswithdecisi
Page 18:
thepharmaceuticalcompany,cf.s.23AdvertisingOrder.Remunerationsh
Page 19:
noprofessionalpurpose;forexampleprivate gifts,ticketstosporting
Page 20:
company.Aspartoftheabovemeetings,the companyrepresentativemayco
Page 21:
Legislation Art.17 Allactivitiesrelatingtodialogueand negotiati
Page 22:
Lægemiddelindustriforeningen
Klik for at downloade publikationen som PDF
For at se denne iPaper løsning, kræves Adobe Flash Player og din browser skal understøtte JAVA scripts
Klik her for at hente den nyeste Flash Player